A Better Fix for Food Allergies - The Atlantic
Tami McGraw, severely allergic to red meat, found relief through Xolair, originally for asthma, which also reduced her food allergies. After years of off-label use, Xolair was approved for food allergies in 2023, offering protection against accidental exposure and transforming lives, though it's not a cure. The drug's approval followed a pivotal clinical trial, OUtMATCH, which showed significant improvement in patients allergic to multiple foods. Xolair's potential to treat multiple allergies simultaneously and enhance oral immunotherapy effectiveness is under study.
Highlighted Terms
Related News
Tami McGraw, severely allergic to red meat, found relief through Xolair, originally for asthma, which also reduced her food allergies. After years of off-label use, Xolair was approved for food allergies in 2023, offering protection against accidental exposure and transforming lives, though it's not a cure. The drug's approval followed a pivotal clinical trial, OUtMATCH, which showed significant improvement in patients allergic to multiple foods. Xolair's potential to treat multiple allergies simultaneously and enhance oral immunotherapy effectiveness is under study.